Turning Point Brands credited its nicotine pouch portfolio for driving second-quarter growth, with the company's FRE and ALP brands delivering stronger retail distribution and market penetration.

The company said growth in its Modern Oral segment—which includes nicotine pouches—supported overall Q2 performance, per Tobacco Reporter. Both FRE and ALP saw expanded placement across retail channels during the quarter.

Why It Matters

The results underscore how legacy tobacco companies are leaning into nicotine pouches as a growth engine. Turning Point's Modern Oral division now represents a key revenue driver as traditional smokeless categories face declining demand.

FRE and ALP compete in a crowded U.S. market dominated by ZYN, but regional distribution gains and retailer relationships give smaller brands room to carve out share. Turning Point's Q2 momentum suggests its pouch strategy is gaining traction beyond niche placement.

What's Next

Turning Point hasn't disclosed specific sales figures or market share data for FRE and ALP. Watch for the company's full earnings report for revenue breakdowns and guidance on Modern Oral expansion plans.

Meanwhile, the broader U.S. nicotine pouch market continues to attract investment and new entrants, with FDA authorization timelines shaping which products can scale nationally.

---

SOURCES:
Tobacco Reporter

Where to buy: Compare prices across retailers at PouchFinder.